z-logo
open-access-imgOpen Access
The role of cholesterol metabolism in leukemia
Author(s) -
Liang Zhao,
Huien Zhan,
Xinya Jiang,
Yangqiu Li,
Hui Zeng
Publication year - 2019
Publication title -
blood science
Language(s) - English
Resource type - Journals
ISSN - 2543-6368
DOI - 10.1097/bs9.0000000000000016
Subject(s) - leukemia , malignancy , cholesterol , cancer research , biology , bioinformatics , medicine , immunology
Leukemia is a common hematological malignancy with overall poor prognosis. Novel therapies are needed to improve the outcome of leukemia patients. Cholesterol metabolism reprogramming is a featured alteration in leukemia. Many metabolic-related genes and metabolites are essential to the progress and drug resistance of leukemia. Exploring potential therapeutical targets related to cholesterol homeostasis is a promising area. This review summarized the functions of cholesterol and its derived intermediate metabolites, and also discussed potential agents targeting this metabolic vulnerability in leukemia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here